Updated 2018 NICE guideline on pharmacological treatments for people with ADHD: a critical look

Erlend Faltinsen; Morris Zwi; Xavier Castells; Christian Gluud; Erik Simonsen; Ole Jakob Storebø

doi:10.1136/bmjebm-2018-111110

Updated 2018 NICE guideline on pharmacological treatments for people with ADHD: a critical look

Erlend Faltinsen, Morris Zwi, Xavier Castells, Christian Gluud, Erik Simonsen, Ole Jakob Storebø

Copenhagen Trial Unit Rigshospitalet

24 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	BMJ Evidence-Based Medicine
Vol/bind	24
Udgave nummer	3
Sider (fra-til)	99-102
Antal sider	4
ISSN	1356-5524
DOI	https://doi.org/10.1136/bmjebm-2018-111110
Status	Udgivet - 2019

Adgang til dokumentet

10.1136/bmjebm-2018-111110

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{4a59ae363ae64a2cad52dbe0401c1f11,

title = "Updated 2018 NICE guideline on pharmacological treatments for people with ADHD: a critical look",

keywords = "clinical pharmacology, mental health, Central Nervous System Stimulants/adverse effects, Humans, Adolescent, Lisdexamfetamine Dimesylate/adverse effects, Methylphenidate/adverse effects, Adult, United Kingdom, Attention Deficit Disorder with Hyperactivity/drug therapy, Child, Practice Guidelines as Topic",

author = "Erlend Faltinsen and Morris Zwi and Xavier Castells and Christian Gluud and Erik Simonsen and Storeb{\o}, {Ole Jakob}",

year = "2019",

doi = "10.1136/bmjebm-2018-111110",

language = "English",

volume = "24",

pages = "99--102",

journal = "BMJ Evidence-Based Medicine",

issn = "1356-5524",

publisher = "BMJ Publishing Group",

number = "3",

}

TY - JOUR

T1 - Updated 2018 NICE guideline on pharmacological treatments for people with ADHD

T2 - a critical look

AU - Faltinsen, Erlend

AU - Zwi, Morris

AU - Castells, Xavier

AU - Gluud, Christian

AU - Simonsen, Erik

AU - Storebø, Ole Jakob

PY - 2019

Y1 - 2019

KW - clinical pharmacology

KW - mental health

KW - Central Nervous System Stimulants/adverse effects

KW - Humans

KW - Adolescent

KW - Lisdexamfetamine Dimesylate/adverse effects

KW - Methylphenidate/adverse effects

KW - Adult

KW - United Kingdom

KW - Attention Deficit Disorder with Hyperactivity/drug therapy

KW - Child

KW - Practice Guidelines as Topic

UR - http://www.scopus.com/inward/record.url?scp=85058386127&partnerID=8YFLogxK

U2 - 10.1136/bmjebm-2018-111110

DO - 10.1136/bmjebm-2018-111110

M3 - Journal article

C2 - 30530806

SN - 1356-5524

VL - 24

SP - 99

EP - 102

JO - BMJ Evidence-Based Medicine

JF - BMJ Evidence-Based Medicine

IS - 3

ER -